Cross-reactive myelin antibody induces renal pathology

References

• Cohen PL. Systemic autoimmunity. Fundamental immunology5th ed., WE Paul. Lippincott Williams & Wilkins, Philadelphia 2003; 1371–1399
   Google Scholar
• Calabresi PA, Austin H, Racke MK, Goodman A, Choyke P, Maloni H, McFarland HF. Impaired renal function in progressive multiple sclerosis. Neurology 2002; 59: 1799–1801
   PubMed Web of Science ®Google Scholar
• Whitaker JN, Dowling PC, Cook SD. Immunofluorescent studies of the kidney in human neurologic disorders. J Neuropathol Exp Neurol 1971; 30: 129–130
   Google Scholar
• Daar AS, Fabre JW. Organ-specific IgM autoantibodies to liver, heart and brain in man: Generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis. Clin Exp Immunol 1981; 45: 37–47
   PubMed Web of Science ®Google Scholar
• Matsiota P, Blancher A, Doyon B, Guilbert B, Clanet M, Kouvelas ED, Avrameas S. Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann Inst Pasteur Immunol 1988; 139: 99–108
   PubMedGoogle Scholar
• Tachovsky TG, Lisak RP, Koprowski H, Theofilopoulos AN, Dixon FJ. Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet 1976; 2: 997–999
   PubMed Web of Science ®Google Scholar
• Tanphaichitr K. Multiple sclerosis associated with eosinophilic vasculitis, pericarditis, and hypocomplementemia. Arch Neurol 1980; 37: 314–315
   Google Scholar
• Achari AN, Trontelj JV, Campos DJ. Multiple sclerosis and myasthenia gravis. A case report with single fiber electromyography. Neurology 1976; 26: 544–546
   Google Scholar
• Esiri MM. Immunoglobulin-containing cells in multiple-sclerosis plaques. Lancet 1977; 2: 478
   PubMed Web of Science ®Google Scholar
• Woyciechowska JL, Brzosko WJ. Immunofluorescence study of brain plaques from two patients with multiple sclerosis. Neurology 1977; 27: 620–622
   PubMedGoogle Scholar
• Aita JF, Snyder DH, Reichl W. Myasthenia gravis and multiple sclerosis: An unusual combination of diseases. Neurology 1974; 24: 72–75
   Google Scholar
• Meloff K. Multiple sclerosis and polyarteritis (Letter to the Editor). Archiv Neurol 1980; 37: 786
   Google Scholar
• Tsunoda I, Kuang L-Q, Theil DJ, Fujinami RS. Antibody association with a novel model for primary progressive multiple sclerosis: Induction of relapsing-remitting and progressive forms of EAE in H2S mouse strains. Brain Pathol 2000; 10: 402–418
   PubMed Web of Science ®Google Scholar
• Peterson LK, Tsunoda I, Masaki T, Fujinami RS. Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis. J Neuroimmunol 2007; 183: 69–80
   PubMed Web of Science ®Google Scholar
• Peterson LK, Fujinami RS. Molecular mimicry. Autoantibodies2nd ed., Y Shoenfeld, ME Gershwin, P-L Meroni. Elsevier Press, Philadelphia 2006; 13–20
   Google Scholar
• Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu J-M, Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994; 153: 4349–4356
   PubMed Web of Science ®Google Scholar
• Papenfuss TL, Rogers CJ, Gienapp I, Yurrita M, McClain M, Damico N, Valo J, Song F, Whitacre CC. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol 2004; 150: 59–69
   PubMed Web of Science ®Google Scholar
• Greer JM, Sobel RA, Sette A, Southwood S, Lees MB, Kuchroo VK. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 1996; 156: 371–379
   PubMed Web of Science ®Google Scholar
• Libbey JE, Peterson LK, Tsunoda I, Fujinami RS. Monoclonal MOG-reactive autoantibody from progressive EAE has the characteristics of a natural antibody. J Neuroimmunol 2006; 173: 135–145
   PubMedGoogle Scholar
• Mostoslavsky G, Fischel R, Yachimovich N, Yarkoni Y, Rosenmann E, Monestier M, Baniyash M, Eilat D. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: A case for tissue injury by molecular mimicry. Eur J Immunol 2001; 31: 1221–1227
   PubMed Web of Science ®Google Scholar
• Dean EG, Wilson GRA, Li M, Edgtton KL, O'Sullivan KM, Hudson BG, Holdsworth SR, Kitching AR. Experimental autoimmune Goodpasture's disease: A pathogenetic role for both effector cells and antibody in injury. Kidney Int 2005; 67: 566–575
   Web of Science ®Google Scholar
• Kitching AR, Turner AL, Semple T, Li M, Edgtton KL, Wilson GR, Timoshanko JR, Hudson BG, Holdsworth SR. Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: A protective role for IFN-g. J Am Soc Nephrol 2004; 15: 1764–1774
   PubMedGoogle Scholar
• Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 1999; 103: 73–80
   PubMed Web of Science ®Google Scholar
• Boyce NW, Holdsworth SR. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: Evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury. J Immunol 1985; 135: 3918–3921
   Google Scholar
• Boyce NW, Holdsworth SR. Direct antiGBM antibody induced alterations in glomerular permselectivity. Kidney Int 1986; 30: 666–672
   Google Scholar
• Couser WG, Darby C, Salant DJ, Adler S, Stilmant MM, Lowenstein LM. Anti-GBM antibody-induced proteinuria in isolated perfused rat kidney. Am J Physiol 1985; 249: F241–F250
   Google Scholar
• Alpers CE. The kidney. Robbins' pathologic basis of disease7th ed., V Kumar, AK Abbas, N Fausto. Elsevier Saunders, Philadelphia 2005; 955–1021
   Google Scholar
• Nolan CR, McKinney TD, Forland M. Urinalysis and renal function tests. Internal medicine5th ed., JH Stein. Mosby, St Louis 1998
   Google Scholar
• Anonymous. Clinical evaluation of genitourinary disorders. The Merck manual of diagnosis and therapy17th ed., MH Beers, R Berkow. Merck & Co., Inc., Whitehouse Station 1999; 1803–1814
   Google Scholar
• Riboldi P, Gerosa M, Moroni G, Radice A, Allegri F, Sinico A, Tincani A, Meroni PL. Anti-DNA antibodies: A diagnostic and prognostic tool for systemic lupus erythematosus?. Autoimmunity 2005; 38: 39–45
   PubMed Web of Science ®Google Scholar
• Asakura K, Miller DJ, Pogulis RJ, Pease LR, Rodriguez M. Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes. Mol Brain Res 1995; 34: 283–293
   PubMedGoogle Scholar
• Asakura K, Miller DJ, Pease LR, Rodriguez M. Targeting of IgMk antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci 1998; 18: 7700–7708
   PubMed Web of Science ®Google Scholar
• Gaynor B, Putterman C, Valadon P, Spatz L, Scharff MD, Diamond B. Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci USA 1997; 94: 1955–1960
   PubMed Web of Science ®Google Scholar
• Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 1998; 188: 29–38
   PubMed Web of Science ®Google Scholar
• Gardinier MV, Amiguet P, Linington C, Matthieu J-M. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J Neurosci Res 1992; 33: 177–187
   PubMed Web of Science ®Google Scholar
• Williamson RA, Burgoon MP, Owens GP, Ghausi O, Leclerc E, Firme L, Carlson S, Corboy J, Parren PW, Sanna PP, Gilden DH, Burton DR. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A 2001; 98: 1793–1798
   PubMedGoogle Scholar